Bladder cancer recurrence by implantation of exfoliated cells: Is y-linolenic acid an effective tumoricidal agent?

British Journal of Urology

Volumn 82, Issue 1, 1998, Pages 122-126

  Solomon, L Z ^a,b   Jennings, A M ^a   Foley, S J ^a   Birch, B R ^a   Cooper, A J ^a  

^a UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^b ST MARY S HOSPITAL   (United Kingdom)

Author keywords

Bladder cancer; Exfoliated cells; Gamma linolenic acid; Intravesical chemotherapy; Tumoricide; Water

Indexed keywords

ALBUMIN; EPIRUBICIN; GAMMA LINOLENIC ACID; MITOMYCIN C; PROTEIN; WATER;

ADHERENT CELL; ARTICLE; BIOMASS; BLADDER CANCER; BLADDER IRRIGATION; CANCER CELL; CANCER RECURRENCE; CELL LINE; CLONOGENIC ASSAY; COLONY FORMATION; CONTAMINATION; CONTROLLED STUDY; DRUG EFFICACY; HUMAN; HUMAN CELL; IMPLANTATION; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TRANSURETHRAL RESECTION; UROTHELIUM;

ANTIBIOTICS, ANTINEOPLASTIC; CARCINOMA, TRANSITIONAL CELL; CELL ADHESION; DRUG RESISTANCE, NEOPLASM; EPIRUBICIN; GAMMA-LINOLENIC ACID; HUMANS; MITOMYCIN; NEOPLASM RECURRENCE, LOCAL; NEOPLASM SEEDING; SERUM ALBUMIN; TUMOR CELLS, CULTURED; TUMOR STEM CELL ASSAY; URINARY BLADDER NEOPLASMS; WATER;

EID: 0031868631     PISSN: 00071331     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Torti FM, Lum BL, Superficial bladder cancer: risk of recurrence and potential role for Interferon therapy. Cancer 1987; 59: 613
2. Dalesio 0. Schulman CC, Sylvester R et al. Prognostic factors in superficial bladder tumors. A study of the European Organization for Research on Treatment of Cancer: Genitourinary Tract Cancer Cooperative Group. J Vrol 1983; 129: 730-3
3. Heney NM, Nocks BN, Daly JJ et al Ta and T1 bladder cancer: location, recurrence and progression. Br JUrol 1982; 54: 152-7
4. Page BH, Levison VB, Curwen MP, The site of recurrence of noninfiltrating bladder tumours. Br J Urol 1978; 50: 237
5. McDonald DF, Thorson T, Clinical implications of transplantability of induced bladder tumours to intact transitional epithelium in dogs. J Urol 1956; 75: 690-4
6. Weldon TE, Soloway MS, Susceptibility of urothelium to neoplastic cellular implantation. Urology 1975; 5: 824-7
7. Hyacinthe LM, Jarrett TW, Gordon CS, Vaughan ED, Whalen GF, Inhibition of bladder tumor cell implantation in cauterized urothelium, without inhibition of healing, by a fibronectin related peptide GRGDS, Ann Surg One 1995: 2: 450-6
8. Oosterlink W, Kurth KH, Schröder F et al. A prospective EORTC GU Group randomised trial (30863) comparing transurethral resection followed by a single intravesical instillation of Epirubicin or water in single stage Ta, Tl papillary carcinoma of the bladder. J Ural 1993; 149: 749-52
9. ToIIey DA, Hargreave TB, Smith PH et al. Effects of intravesical mitomycin C on recurrence of newly diagnosed superficial bladder cancer: Interim report from the Medical Research Council sub-group on superficial bladder cancer (Urological Cancer Working Party). Er Med J1988; 296: 1759-61
10. Hall RR, Applications of clinical trials to the care of patients with bladder cancer. Eur Urol 1997: 31: 42-6
11. Bulkier M, Moskovitz B, Ginesin Y, Levin DR, Effect of distilled water and bacillus Calmette-Guerin on exfoliated bladder tumor cells. Eur Urol 1991; 19: 319-21
12. Koontz WW, Prout GR, Smith W, The use of intravesical thiotepa in the management of non-invasive carcinoma of the bladder. J Urol 1981; 125: 307-12
13. Bracken RB, Johnson DE, Von Eschenbach AC, Role of intravesical mitomycin C in management of superficial bladder tumours. Urology 1980; 16: 11-5
14. Soloway MS, Master S, Urothelial susceptibility to tumor cell implantation. Cancer 1980; 46: 1158-63
15. Martinez Pineiro JA, Leon JJ, Martinez Pineiro J Jr et al. Bacillus Calmette-Guerin versus doxorubicin versus thiotepa: a randomized prospective study in 202 patients with superficial bladder tumors. J Urol 1990; 143: 502-6
16. Morales A, Eidinger D, Bruce AW, Intracavitary bacillus Calmette-Guerin in the treatment of superficial bladder tumors. J Urol 1976; 116: 180-2
17. Nakagawa M, Emoto A, Nasu N et al. Clinical significance of multi-drug resistance associated protein and P-glycoprotein in patients with bladder cancer. J Urol 1997: 157: 1260-5
18. Docherty JG, McGregor JR, Purdie CA, Galloway DJ, O'Dwyer PJ, Efficacy of tumoricidal agents in vitro and in vivo. Br I Surg 1995; 82: 1050-2
19. Solomon LZ, Jennings AM, Hayes MC, Bass PS, Birch BR, Cooper AJ, Is gamma linolenic acid an effective intravesical agent for superficial bladder cancer? in vitro cytotoxicity and in vivo tolerance studies. Urol Res 1998; 26: 11-15
20. Hayes MC, Cooper AJ, Gough A, Smart CJ, Resistance to mitomycin C is associated with cross-resistance to epirublcin and over-expression of MDR-1. Br J Urol 1997; 79: 22
21. Masters JR, Hepburn PJ, Walker L et al. Tissue culture model of transitional cell carcinoma: characterization of twenty-two human urothelial cell lines. Cancer Res 1986; 46: 3630-6
22. Skipper D, Cooper AJ, Marston JE, Taylor I, Exfoliated cells and in vitro growth in colorectal cancer. Br J Surg 1987; 74: 1049-10
23. Heiz F, Deitch D, Adler SA et al. Short term culture of exfoliated cells from the urine of patients with bladder tumour. Urol Res 1993; 21: 23-6
24. Begin ME, Das UN, Ells G et al. Selective killing of human cancer cells by polyunsaturated fatty acids. Prostaglandins, Leucotrienes, Essential Fatty Acids 1985; 19: 177-86
25. Booyens J, Engelbrecht P, Le Roux S et al. Some effects of the essential fatty acids linoleic acid and alpha-linolenic acid and of their metabolites gamma-linolenic acid, arachidonic acid, eicosapentaenoic acid, docosahexaenoic acid, and of prostaglandins Al and El on the proliferation of human osteogenic sarcoma cells in culture. Prostaglandins Leukotrienes Med 1984: 15: 15-33
26. Begin ME, Tumour cytotoxicity of essential fatty acids. Nutrition 1989; 15: 258-65
27. Grammatikos SI, Subbaiah PV, Victor TA, Miller WM. n-3 and n-6 fatty acid processing and growth effects in neoplastic and non-cancerous human mammary epithelial cell lines. Br JCancer 1994; 70: 219-26
28. Ravicahndran DR, Cooper AJ, Johnson CD, Growth inhibitory effects of lithium gamma linolenic acid on pancreatic cell lines: the influence of albumin and iron. Eur J Cancer 1998; in press
29. Das UN, Prasad VVSK, Raia Reddy D, Local application of gamma linolenic acid in the treatment of human gliomas. Cancer Lett 1995; 94: 147-50
30. Southgate J, Pitt E, Trejdosiewicz LK, The effects of dietary fatty acids on the proliferation of normal human urothelial cells in vitro. Br J Cancer 1996; 74: 728-35
31. Spector AA, Burns CP, Biological and therapeutic potential of membrane lipid modification in tumours. Cancer Res 1987; 47: 4529-37